ÌÇÐÄvlog

[Skip to Navigation]
Sign In

Year

Day

November 20, 2024
Brief Report

Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in Psoriasis

Abstract Full Text
JAMA Dermatol. Published online November 20, 2024. doi:10.1001/jamadermatol.2024.4433

This cohort study explores whether systemic inflammation is a mediator of the association between psoriasis skin disease severity and cardiovascular disease.

Consensus Statement

Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement

Abstract Full Text
has active quiz
JAMA Dermatol. Published online November 20, 2024. doi:10.1001/jamadermatol.2024.4593

This Consensus Statement describes the results of an international expert survey, creating clinical guidance for prescribing low-dose oral minoxidil to patients with hair loss.

JAMA Dermatology Clinicopathological Challenge

Annular Eroded Plaque With Honey-Colored Crusting On Scrotum

Abstract Full Text
has active quiz
JAMA Dermatol. Published online November 20, 2024. doi:10.1001/jamadermatol.2024.4424

A man in his 40s presented with a dry erythematous, annular plaque with focal erosion and a collarette of desquamative, honey-colored crusting on the scrotum. What is your diagnosis?

Comment & Response

Salt and Atopic Dermatitis

Abstract Full Text
JAMA Dermatol. Published online November 20, 2024. doi:10.1001/jamadermatol.2024.4914

Salt and Atopic Dermatitis

Abstract Full Text
JAMA Dermatol. Published online November 20, 2024. doi:10.1001/jamadermatol.2024.4917

Salt and Atopic Dermatitis—Reply

Abstract Full Text
JAMA Dermatol. Published online November 20, 2024. doi:10.1001/jamadermatol.2024.4911
Correction

Error in Figure 2

Abstract Full Text
free access
JAMA Dermatol. Published online November 20, 2024. doi:10.1001/jamadermatol.2024.5294
November 16, 2024
Editorial

Lowell A. Goldsmith, MD, MPH, 1938-2024—A Personal Remembrance From 3 Friends

Abstract Full Text
JAMA Dermatol. Published online November 16, 2024. doi:10.1001/jamadermatol.2024.5359
November 13, 2024
Viewpoint

Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention

Abstract Full Text
JAMA Dermatol. Published online November 13, 2024. doi:10.1001/jamadermatol.2024.4567

This Viewpoint describes what dermatologists should know about doxycycline postexposure prophylaxis (doxyPEP) for bacterial sexually transmitted infection (STI) prevention, specifically syphilis, chlamydia, and gonorrhea.

Original Investigation

Skin Cancer Diagnosis by Lesion, Physician, and Examination Type: A Systematic Review and Meta-Analysis

Abstract Full Text
JAMA Dermatol. Published online November 13, 2024. doi:10.1001/jamadermatol.2024.4382

This systematic review and meta-analysis assesses the accuracy of skin cancer diagnosis by skin lesion type, physician specialty and experience, and physical examination method.

Brief Report

Wound Characteristics Among Patients Exposed to Xylazine

Abstract Full Text
JAMA Dermatol. Published online November 13, 2024. doi:10.1001/jamadermatol.2024.4253

This case series systematically characterizes the location, wound bed surface, and chronicity of wounds among persons with confirmed xylazine exposure.

Observation

Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome

Abstract Full Text
JAMA Dermatol. Published online November 13, 2024. doi:10.1001/jamadermatol.2024.4342

This case report describes a patient with Sweet syndrome whose condition improved with spesolimab after failure of high-dose corticosteroids.

November 6, 2024
Editorial

COVID-19 as a Risk Factor For Autoimmune Skin Disease

Abstract Full Text
JAMA Dermatol. Published online November 6, 2024. doi:10.1001/jamadermatol.2024.4222
Original Investigation

Psoriasis Risk With Immune Checkpoint Inhibitors

Abstract Full Text
JAMA Dermatol. Published online November 6, 2024. doi:10.1001/jamadermatol.2024.4129

This cohort study evaluates the psoriasis risk associated with the use of immune checkpoint inhibitors among patients with cancer.

Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19

Abstract Full Text
JAMA Dermatol. Published online November 6, 2024. doi:10.1001/jamadermatol.2024.4233

This cohort study investigates the long-term risk of autoimmune and autoinflammatory diseases among patients in South Korea who had a COVID-19 diagnosis using an extended observational period.

Images in Dermatology

Madelung Disease

Abstract Full Text
has active quiz
JAMA Dermatol. Published online November 6, 2024. doi:10.1001/jamadermatol.2024.4217

This case report describes nontender, soft, and mobile tissue proliferations involving the anterior, lateral, and posterior neck spaces and diffuse, nonencapsulated soft tissue masses that were widely distributed across superficial and deep fascial spaces.

Research Letter

Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome

Abstract Full Text
JAMA Dermatol. Published online November 6, 2024. doi:10.1001/jamadermatol.2024.4445

This case series examines treatment with anti–programmed cell death 1 (PD1) immunotherapy for patients with basal cell nevus syndrome.

×